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ABSTRACT
Objective: To describe the main clinical, therapeutic and epidemiological characteristics of women diagnosed 
with breast cancer in the Pérola Byington Hospital, between the years 2000 and 2006. Methods: This was a cross 
sectional study and quantitative nature. Data collection was performed using a structured form. Results: Most 
of the women were married, white, with low education, catholic and housewives. About 75% had at least one 
pregnancy, and 33.1% breastfed. Just over 30% had hormone replacement. Smokers were 14.7% and 2.7% were 
ex-smokers. The initial clinical staging of highest incidence are the II and III, representing together 66.5% of cases. 
Before the first consultation, 91.3% of women had no diagnosis of breast cancer and no prior treatment. Conclusion: 
Knowing the profile of women affected by breast cancer is essential for targeting of resources and decision-making. 
Descriptors: Breast neoplasms; Epidemiology; Women’s health.
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RESUMO
Objetivo: Descrever as principais características clínico-terapêuticas e 
epidemiológicas de mulheres diagnosticadas com câncer de mama no 
Hospital Pérola Byington, entre os anos de 2000 e 2006. Métodos: Trata-
se de um estudo de corte transversal e natureza quantitativa. A coleta de 
dados foi realizada por meio de um formulário estruturado. Resultados: 
A maior parte das mulheres era casada, branca, com baixa escolaridade, 
católica e do lar. Cerca de 75% tiveram pelo menos uma gravidez, e 33,1% 
amamentaram. Pouco mais de 30% fizeram reposição hormonal. Eram fu-
mantes 14,7%, e 2,7% ex-fumantes. Os estadiamentos clínicos iniciais de 
maior incidência são os II e III, juntos representam 66,5% dos casos. Cerca 
de 91,3% das mulheres não apresentavam diagnóstico do tumor de mama 
e nem tratamento anterior à primeira consulta. Conclusão: Conhecer o 
perfil das mulheres acometidas pelo câncer de mama é imprescindível 
para o direcionamento de recursos e tomadas de decisão.
Descritores: Neoplasias da mama; Epidemiologia; Saúde da mulher.
RESUMEN
Objetivo: Describir las principales características clínicas, terapéuticas y 
epidemiológicas de las mujeres diagnosticadas con cáncer de mama en el 
Hospital Pérola Byington, entre los años 2000 y 2006. Métodos: Se realizó 
un estudio de corte transversal y de naturaleza cuantitativa. La recolección 
de datos se realizó mediante un formulario estructurado. Resultados: 
La mayoría de las mujeres estaban casadas, blancas, con bajo nivel de 
educación, católica y dueña de casa. Aproximadamente el 75% tenía al 
menos un embarazo, y el 33,1% con leche materna. Algo más del 30% 
tenían de reemplazo hormonal. Las fumadoras eran el 14,7% y el 2,7% ex 
fumadoras. La estadificación clínica inicial de mayor incidencia son la II 
y III, en conjunto representan 66,5% de los casos. Sobre el 91,3% de las 
mujeres no tenían un diagnóstico de tumor de mama y no se sometieron a 
tratamiento previo a la primera consulta. Conclusión: Conocer el perfil de 
las mujeres afectadas por cáncer de mama es esencial para la orientación 
de los recursos y la toma de decisiones.
Descriptores: Neoplasias de la mama; Epidemiología; Salud de la mujer.
INTRODUCTION
The breast cancer is the most common cause of death 
among women and, except for nonmelanoma skin cancer, is 
the most prevalent in 140 countries. For the years 2014-2015 
it is estimated that in Brazil there will be 57,000 new cases.1 
The Southeast and South regions are characterized by 
the predominance of breast cancer, with São Paulo being the 
Brazilian state with the highest number of cases foreseen for 
the period from 2014 to 2015: 16,160 new cases.3
Against the impact of the disease, it has been created a set 
of systematic information about the behavior, characteristics 
and trends of the disease that aim to collect, analyze and 
classify information of all new cases of cancer, in order to 
build reliable statistical data of the event of cancer in the 
population in question. 
Such tools, called Population-Based Cancer Registry 
(PBCR) and Cancer Hospital Registry (CHR), assist in the 
monitoring and evaluation of control activities and cancer 
research, and help in taking forward the decision to the 
effects of the treatments.4,5 
Registering this data is not always an easy task, 
considering the lack of material and human resources. The 
risk of distortion is real,4 and completeness is, often, bad.5 
However, there is availability of training and updating of 
professionals aiming at improved quality.
The information contained in RHCS give grants to several 
studies, including the survival6 and analysis of temporal 
trends of the phenomena associated with the disease,5 
also being possible all characterization of the population 
according to clinical and epidemiological variables.
Given the above and disease-related social impact, this 
study is envisioned that can assist in knowledge about the 
profile of women affected by breast cancer and also offer 
grants to develop strategies for prevention, early detection 
and treatment of this cancer.
OBJECTIVE
To describe the clinical-therapeutic, socio-demographic 
and epidemiological profile of women diagnosed with breast 
cancer treated at Pérola Byington Hospital.
METHOD
This is a cross-sectional study, of a quantitative nature, 
held at the Pérola Byington Hospital, Health Reference Center 
for Women, in São Paulo. Data were extracted from the RHC 
and the medical records of women treated in this hospital.  
The study sample was random among women who 
received the first diagnosis of breast cancer between the years 
2000 and 2006, totaling 299 records.
The variables were defined from the Cancer Hospital 
Records Manual, routines and procedures of INCA,4 
which is the database feeding the Hospital Cancer Registry 
Information System (SisRHC).
Out of the total of the variables, were chosen 16 
sociodemographics, 9 referring to the tumor and 2 referring 
to the treatment, since they were considered to be the most 
interesting for the profile design.
In women who have more than one primary tumor, it 
was considered only the first diagnosis. 
As inclusion criteria, the woman should have done the 
first diagnosis of breast cancer, confirmed by biopsy, in 
service study from 2000 to 2006.
Data collection was performed using a form with the 
sociodemographic and clinical variables. The data collection 
period was from August 2013 to April 2014.
Data were stored in a spreadsheet using Excel program 
and performed the simple frequency of tests for the variables 
using the Statistical Package for the Social Sciences version 19.
The study was approved by the Unifesp Ethics 
Committee’s second opinion No. 572,865.
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RESULTS 
Table 1 shows the sociodemographic profile. The 
predominant age group is between 50 and 69 years (44.15%). 
The average age was 53.95 with a median of 52 and standard 
deviation of 13.5 years. With regard to skin color, 31.5% were 
white and more than 50% of the sample had incompleteness 
of this variable. Married women predominate with 26.4%. As 
for education, 4.7% of the study population reported having 
incomplete primary education, 2% are illiterate and only 0.3% 
have higher level. Among occupations, the predominance of 
women was housewifes with 10%. In variable religion, 30.4% 
were Catholic. 
The incompleteness of the data was an important limiting 
factor in the study, ranging from 52.5% in the variable race/
color and 88.3% in variable education.
Table 1 – Sociodemographic profile of women diagnosed 
with breast cancer and treated at Pérola Byington Hospital 
from January 1, 2000 through December 31, 2006
%NVariables
Age
12.3737Equal to or less than 39 years
29.438840 to 49 years
44.1513250 and 69 years
14.054270 or more
Race/Color
31.895White
5.015Black
0.34Yellow
10.431Brown
52.5157No information
Education
515Incomplete Elementary school 
1.34Complete Elementary school 
3.09Complete High School
0.31Incomplete Higher Education
2.06Illiterate
88.3264No information
Table 1 continued – Socio-demographic profile of women 
diagnosed with breast cancer and treated at Pérola Byington 
Hospital from January 1, 2000 through December 31, 2006
%NVariables
Marital Status
7.021Single
26.479Married
4.012Divorced
6.018Widowed
0.72Stable Union
55.9167No information
%NVariables
Occupation
1030Housewife
3.09Retired
3.310Housekeeper
4.714Others
79236No information
Religion
30.491Catolic
1133Evangelical/Christian
1.03Spiritist
0.62Do not have any 
0.72Jehovah’s Witness
56.2168No information
100299Total
AGE - Average: 53.95; Median: 52.0; Trend: 44; Standard deviation: 13.5; 
Minimum: 19; Maximum: 99.
As described in Table 2, the majority (75.3%) of women 
had at least one pregnancy. Regarding age at first birth, 
39.8% were under 30 years, while aged over 30 accounted 
for 8% of the sample. Of the total, 33.1% of women breastfed 
and 9.7% did not. 
As for menarche, 21.40% of the cases occurred between 
11 and 15 years. The trend for age was 14 years, with a 
minimum of 9 and a maximum of 19.
The variable menopause had 21.40% of women aged 
between 44 and 50 years. The trend was 50 years and a 
minimum age of 34 and maximum of 57.
About 35% of women were postmenopausal, followed by 
20.4% in premenopausal.
Those who used contraceptives made up 4.3%, and 25.8% 
did not. Of the 299 records, 30.8% underwent hormone 
replacement therapy and 14.4% did not.
As for family history related to breast cancer, 46.5% of 
women reported no history, followed by 14.4% who had 
cases in the family. 
With regard to lifestyle and modifiable risk factors, 54.2% 
of women were non-smokers, 14.7% were smokers and 2.7% 
ex-smokers. Alcoholism was denied in 56.9% of cases and 
only 0.3% was confirmed. 
By analyzing Table 2, it is observed that the item 
no information had frequency of 16.42% to 72.91% 
between variables.
(To be continued)
(Continuation)
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Table 2 – Characteristics of personal and family history of 
women diagnosed with breast cancer and treated at Pérola 
Byington Hospital from January 1, 2000 through December 
31, 2006
%NVariables
Nulliparity
8.425Yes
75.3225No
16.449No information
Age at First Birth
39.8119≤ 30 years
3.09> 30 years
8.024Not applicable
49.2147No information
Age of Menarche
3.019≤ 10 years
21.406411 to 15 years
2.688≥ 16 years
72.91218No information
Table 2 continuation – Characterization of personal and 
family history of women diagnosed with breast cancer and 
treated at Pérola Byington Hospital from January 1, 2000 
through December 31, 2006
%NVariables
Age of Menopause
3.6811< 40 years
21.406440 – 55 years
1.003> 55 years
18.4055Not applicable
55.52166No information
Hormonal Status at Diagnosis
20.461Pre Menopause
35.1105Post Menopause
44.4133No information
Use of Contraceptive
4.313Yes
25.877No
69.9209No information
Hormone Replacement
3.09Yes
30.892No
66.2198No information
Family History of Breast Cancer
14.443Yes
46.5139No
39.1117No information
Breast-Feeding
33.199Yes
9.729No
57.2171No information
Table 2 continuation – Characterization of personal and 
family history of women diagnosed with breast cancer and 
treated at Pérola Byington Hospital from January 1, 2000 
through December 31, 2006
%NVariables
Alcoholism
0.31Yes
56.9170No
42.8128No information
Smoking
14.042Yes
54.2162No
2.78Ex-Smoker
29.187No information
100299Total
AGE AT MENARCHE - Trend: 14; Minimum: 9; Maximum: 18. AGE AT 
MENOPAUSE - Trend: 50; Minimum: 34; Maximum: 57.
In 95.4% of the sample, the tumor location was not 
topographically described, being used the initials NOS, 
which corresponds to the unspecified mammary gland. The 
upper outer quadrant was described at 2.3%, followed by 
Superior Internal Quadrant at 1.7%; the Lower Quadrant 
Internal and External Lower Quadrant were each 0.3%. 
The initial clinical staging of highest incidence was isolated 
staging II in 45.82% of cases, followed by stage III with 
20.73%, 15.72% stage I and stage IV at 3.68%, the percentage 
of non-completion was 14.05.
There was distant metastasis in 13.63% of the sample. 
Of this total, 5.52% of women had metastasis in the bones, 
joints and articular cartilage of the limbs, 3.9% in the bronchi 
and lungs, 1.95% in the liver and biliary tract, 0.97% in the 
lymph nodes, 0.97 % in the brain and 0.32% in ill-defined 
locations. Of the patients, 13 relapsed, totaling 4.4% of the 
sample, of the total 2.7% were local recurrence and 1.7% 
regional recurrence. The rest is divided into 86.3% who did 
not have any and 9.4% without information. 
The predominant laterality was left in 55.9% of the cases. 
In relation to hormone receptors, 51.5% was positive for 
Estrogen Receptor, 25.8% negative and 8.7% inconclusive. To 
Progesterone Receptor, 43.5% of cases were positive, negative 
39.1%, and 2.7% inconclusive. As to the tumor markers, the 
c-erbB-2 was positive in 30.1% of cases, negative in 34.4%, 
inconclusive in 4%. The tumor marker P53 was positive in 
22.4% of cases, negative in 33.1% and 2.7% inconclusive.
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Table 3 - Clinical characterization of women diagnosed with 
breast cancer and treated at Pérola Byington Hospital from 
January 1, 2000 through December 31, 2006
%NVariables
Location of the Primary Tumor
1.75Breast, Internal Superior Quadrant
0.31Breast, Internal Lower Quadrant
2.37
Breast, External Superior Qua-
drant
0.31Breast, External Lower Quadrant
95.4285Breast, SOE
Laterality
55.9167Left
42.5127Right
1.34Bilateral
0.31No information
Estrogen Receptor
51.5154Positive
25.877Negative
8.726Inconclusive
14.042No information
Progesterone Receptor
43.5130Positive
39.1117Negative
2.78Inconclusive
14.744No information
Tumor Marker c-erbB-2 
30.190Positive
34.4103Negative
4.012Inconclusive
31.494No information
Table 3 continued - Clinical characterization of women diag-
nosed with breast cancer and treated at Pérola Byington 
Hospital from January 1, 2000 through December 31, 2006
%NVariables
Tumor marker P53 
22.467Positive
33.199Negative
2.78Inconclusive
41.8125No information
Metastasis
80.2247No
1.956Liver and Intra-Hepatic vias
3.912Bronchi and Lungs
5.5217
Bones, Joints and Cartilage  
Articular Member
0.973Encephalon
0.321
Other Locations and Locations 
ill-defined
%NVariables
Metastasis
0.973Lymph nodes
6.1719No information
Recurrence
2.78Local
1.75Regional
86.3258No
9.428No information
Staging
15.7247I
45.82137II
20.7362III
3.6811IV
14.0542No information
100299Total
From the 299 records analyzed, 91.3% were women 
who had a no previous diagnosis of breast tumor and no 
previous treatment to the first consultation at the Pérola 
Byington Hospital. Previous diagnoses corresponded to 
7.7% and 1% had a diagnosis and had previous treatment 
in another service.
Of the total sample, 32.44% underwent the following 
treatments Surgery, Chemotherapy, Radiotherapy and 
Hormone Therapy. 25.08% had only Surgery, Chemotherapy 
and Radiotherapy. 
Table 4 - Characterization of the treatment of women with 
diagnosed breast cancer and treated at Pérola Byington 
Hospital fromanuary 1, 2000 through December 31, 2006
%NVariables
Treatments and Combinations
6.6920Just Surgery
1.344Just Chemotherapy
5.416Surgery + Chemotherapy
4.714Surgery + Radiotherapy
6.0218Surgery + Hormone Therapy
0.331Chemotherapy + Hormone 
Therapy
25.0875Surgery + Chemotherapy + 
Radiotherapy
8.0324Surgery + Chemotherapy + Hor-
mone Therapy
8.0324Radiotherapy + Surgery + Hor-
mone Therapy
0.331Chemotherapy + Radiotherapy + 
Hormone Therapy
32.4497Surgery + Chemotherapy + 
Radiotherapy + Hormone Therapy
1.75No treatment
(To be continued) (To be continued)
(Continuation)
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%NVariables
Diagnosis and Previous 
Treatment
91.3273No Diagnosis and No Treatment
1.03With Diagnosis and With 
Treatment 
7.723With Diagnosis and Without 
Treatment 
100299Total
DISCUSSION
The age range for women corroborates previous studies7 
that claim that as the age increases the risk for breast cancer 
increase,8 being relatively rare before 35 years.9
The predominance of color converge with previous 
findings.7,10 However, one cannot conclude much about 
this variable, considering the small number of non-white 
women, as well as high rate of incompleteness.7 
Married women are also the majority in similar studies,11,12 
which say it is important the presence of a companion to 
cope with the disease due to the large generated psychosocial 
impact, but their absence does not constitute a risk factor.7,11,12
A low educational level of these women is observed, 
similar to results found in the same character studies.7,12 
“Household” women are also most in the Pinho and 
Coutinho study.13
Another study also points to the primacy of the Catholic 
religion.12 According to Caldeira, Carvalho and Vieira 
(2014),14 spiritual distress is present during the treatment of 
cancer, being the importance of religion high, and requiring 
preparation of nurses to assist in the process. 
In relation to pregnancy and age at first birth, gender 
studies also found similar results,10,15 reporting most as 
young mothers.
Most women breastfed. Although not proven by science, 
breastfeeding has already been characterized as a protective 
factor against breast cancer in other studies.16,17 
As for the age of menarche, the result is similar to the Paiva 
et al. study (2002),10 which showed maximum and minimum 
of 9 and 20 respectively. Regarding the age of menopause, the 
data found can also be glimpsed in other studies,10,15 and the 
predominance of women in the postmenopausal period.18 
On the correlation between contraceptive use and breast 
cancer, some authors claim not to have observed a positive 
correlation,19 diverging from another group that defends 
this association.11 In relation to hormone replacement 
therapy, a study shows that this factor now is at risk after the 
fifth year of use.19
It is already clear in the literature that breast cancer in 
first-degree relatives, particularly mother and sister, increase 
the risk by up to twice of having breast cancer.20
With regard to lifestyle and modifiable risk factors, 
the National Cancer Institute21 says that smokers, former 
smokers and passive smokers women have higher risk of 
developing cancer, especially after menopause. The intake of 
alcohol is also a risk factor for all types of cancer, including 
breast cancer.22
The location of the tumor corresponding to the mammary 
gland, without specification, also prevailed in a study carried 
out in the state of Espírito Santo,23 showing failure in the 
trusted registration of information.
The staging is one of the most important variables when 
it comes to survival, and its prevalence in I and II (initial) is 
associated with better prognosis for women and may have a 
survival rate of 97% in 5 years; if diagnosed at the advanced 
stage, these chances fall sharply.7 
The presence of both recurrence and metastasis has 
been associated with worse prognosis.23 Most cases do not 
progressed to metastases, converging with results from a 
previous study.24
The left laterality is predominant in the literature and, 
in addition to this, was also found in a study carried out in 
Espírito Santo.23
Cintra et al. (2012),18 in their study on hormone receptors 
in breast cancer, also found higher prevalence of negative 
cases of tumor marker c-erbB-2. Authors show large 
differences in prognosis according to treatment received.25 
CONCLUSION
Breast cancer is a multifactorial condition, which allows 
the study of many risk factors. Among the women surveyed, 
the majority presented a profile similar to that described 
in the literature, such as age and stage. It is important to 
highlight the poor quality of RHC hospital studied, as well as 
from the medical records, especially the socio-demographic 
data, which prevailed without information and could have 
been used to better define the profile of these women.
More studies are needed to trace the profile of women 
with breast cancer, places committed to the teaching-
research binomial, with professionals who dedicate 
themselves to faithfully filling out forms and the patient’s 
records, to make possible the advance of science with the use 
of secondary data, helping in the planning of specific health 
agendas, resource allocation, continuing education, as well 
as in actions to promote health, early detection of diseases 
and conduct for treatment.
(Continuation)
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